K. Seino

1.3k total citations
44 papers, 947 citations indexed

About

K. Seino is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, K. Seino has authored 44 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 14 papers in Oncology and 8 papers in Surgery. Recurrent topics in K. Seino's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (6 papers). K. Seino is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (6 papers). K. Seino collaborates with scholars based in Japan, United States and United Kingdom. K. Seino's co-authors include Ryo Otsuka, Masaru Taniguchi, Satoshi Kojo, Haruka Wada, Michishige Harada, Hiroshi Watarai, Hiroshi Wakao, Xiaofeng Jiang, Toshinori Nakayama and Katashi Fukao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

K. Seino

43 papers receiving 925 citations

Peers

Countries citing papers authored by K. Seino

Since Specialization

Citations

This map shows the geographic impact of K. Seino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Seino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Seino more than expected).

Fields of papers citing papers by K. Seino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Seino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Seino. The network helps show where K. Seino may publish in the future.

Co-authorship network of co-authors of K. Seino

This figure shows the co-authorship network connecting the top 25 collaborators of K. Seino. A scholar is included among the top collaborators of K. Seino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Seino. K. Seino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanism and regulation of the complement activity in kidney xenotransplantation 2025 ·Transplantation Reviews ·Takayuki Hirose, Kiyohiko Hotta, Ryo Otsuka, K. Seino	1
2	Amelioration of liver fibrosis with autologous macrophages induced by IL-34-based condition 2025 ·Inflammation and Regeneration ·(unknown), Haruka Wada, (unknown), (unknown), Yoshinori Hasegawa, K. Seino	2
3	iPSCs engrafted in allogeneic hosts without immunosuppression induce donor-specific tolerance to secondary allografts 2025 ·Proceedings of the National Academy of Sciences ·(unknown), R. Kimura, (unknown), Makoto Inoue, K. Seino	0
4	Impact of direct identification of bacteria in blood culture–positive specimens by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry on physician selection of antimicrobial therapy 2024 ·Journal of Infection and Chemotherapy ·Hiroshi Umemura, Hiroyuki Nishiyama, (unknown), K. Seino, Masaki Nakajima, Sachio Tsuchida, Tomohiro Nakayama	1
5	Interleukin-34 cancels anti-tumor immunity by PARP inhibitor 2023 ·Journal of Gynecologic Oncology ·Takayoshi Nakamura, (unknown), Naoki Hama, (unknown), Ryo Otsuka, (unknown), Haruka Wada, Yoshinori Hasegawa, Nao Suzuki, K. Seino	2
6	IL-34, the rationale for its expression in physiological and pathological conditions 2021 ·Seminars in Immunology ·Ryo Otsuka, Haruka Wada, K. Seino	14
7	Macrophage activation syndrome and COVID-19 2020 ·Inflammation and Regeneration ·Ryo Otsuka, K. Seino	97
8	Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells 2020 ·Inflammation and Regeneration ·(unknown), (unknown), Naoki Hama, (unknown), (unknown), Hidehisa Takahashi, Haruka Wada, Ryo Otsuka, Muhammad Baghdadi, K. Seino	6
9	Induction of Macrophage-Like Immunosuppressive Cells from Mouse ES Cells That Contribute to Prolong Allogeneic Graft Survival 2014 ·PLoS ONE ·(unknown), Haruka Wada, Hajime Sasaki, (unknown), Ryo Otsuka, Muhammad Baghdadi, Satoshi Kojo, Tatsuya Chikaraishi, K. Seino	11
10	Clinical significance of side population in ovarian cancer cells 2011 ·Human Cell ·(unknown), Yoichi Kobayashi, Satoshi Kojo, Haruka Wada, K. Seino, Kazushige Kiguchi, Bunpei Ishizuka	35
11	Establishment of an Improved Mouse Model for Infantile Neuroaxonal Dystrophy That Shows Early Disease Onset and Bears a Point Mutation in Pla2g6 2009 ·American Journal Of Pathology ·Haruka Wada, Takuwa Yasuda, Ikuo Miura, Kazuhiko Watabe, Chika Sawa, Hajime Kamijuku, Satoshi Kojo, Masaru Taniguchi, Ichizo Nishino, Shigeharu Wakana, Hisahiro Yoshida, K. Seino	48
12	Plasma thrombopoietin level and platelet indices in hemodialysis patients receiving recombinant human erythropoietin 2009 ·International Journal of Laboratory Hematology ·(unknown), K. Seino, Takuya Mizuno, Makoto Nasu, (unknown), M Fujishima	10
13	RCAI-17, 22, 24–26, 29, 31, 34–36, 38–40, and 88, the analogs of KRN7000 with a sulfonamide linkage: Their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines 2008 ·Bioorganic & Medicinal Chemistry ·Takuya Tashiro, (unknown), Ryusuke Nakagawa, K. Seino, Hiroshi Watarai, Yasuyuki Ishii, Masaru Taniguchi, Kenji Mori	23
14	Critical Role for CXC Chemokine Ligand 16 (SR-PSOX) in Th1 Response Mediated by NKT Cells 2007 ·The Journal of Immunology ·Takeshi Shimaoka, K. Seino, Noriaki Kume, Manabu Minami, Chiyoko Nishime, Makoto Suematsu, Toru Kita, Masaru Taniguchi, Kouji Matsushima, Shin Yonehara	48
15	IL-21–induced Bε cell apoptosis mediated by natural killer T cells suppresses IgE responses 2006 ·The Journal of Experimental Medicine ·Michishige Harada, (unknown), Hiroshi Watarai, Yuko Nagata, Yasuyuki Ishii, Satoshi Kojo, S. Horiguchi, Yoshitaka Okamoto, Toshinori Nakayama, Nobutaka Suzuki, Wen-Chen Yeh, Shizuo Akira, Hiroshi Kitamura, Osamu Ohara, K. Seino, Masaru Taniguchi	95
16	Cutting Edge: Critical Role of CXCL16/CXCR6 in NKT Cell Trafficking in Allograft Tolerance 2005 ·The Journal of Immunology ·Xiaofeng Jiang, Takeshi Shimaoka, Satoshi Kojo, Michishige Harada, Hiroshi Watarai, Hiroshi Wakao, Nobuhiro Ohkohchi, Shin Yonehara, Masaru Taniguchi, K. Seino	64
17	Induction of Regulatory Properties in Dendritic Cells by Vα14 NKT Cells 2005 ·The Journal of Immunology ·Satoshi Kojo, K. Seino, Michishige Harada, Hiroshi Watarai, Hiroshi Wakao, Tetsuro Uchida, Toshinori Nakayama, Masaru Taniguchi	66
18	The effect of alpha-galactosylceramide upon allogenic rejection 2001 ·Transplantation Proceedings ·K. Seino, Kazuhiko Yanagisawa, (unknown), Yasutsugu Takada, (unknown), Masaki Otsuka, Katashi Fukao	5
19	Protection Against Fas-Mediated and Tumor Necrosis Factor Receptor 1-Mediated Liver Injury by Blockade of FADD Without Loss of Nuclear Factor-κB Activation 2001 ·Annals of Surgery ·K. Seino, Yasuhiro Setoguchi, Tetsuya Ogino, Nobuhiko Kayagaki, Hisaya Akiba, Hiroyasu Nakano, Hiroko Taniguchi, Yasutsugu Takada, Kenji Yuzawa, T Todoroki, Yoshinosuke Fukuchi, Hideo Yagita, Ko Okumura, Katashi Fukao	11
20	Long-term graft survival of living-related kidneys after donor-specific transfusion 2000 ·Transplantation Proceedings ·Masaaki Otsuka, Kenji Yuzawa, Yasutsugu Takada, Hideki Taniguchi, Kiyoshi Fukunaga, K. Seino, T Todoroki, Katashi Fukao	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact